Intralymphatic immunotherapy

The use of intralymphatic immunotherapy (ILIT) as a treatment option for allergic rhinitis continues to generate clinical research as reviews of initial cohort studies since the early 2000s reported that 3 ultrasound-guided, antigen injections to the inguinal lymph nodes spaced 4 weeks apart could rapidly improve allergic rhinitis symptoms and provide lasting immune tolerance;1 however, other reviews did not find ILIT to be significantly more efficacious than placebo.2 Original research featured in this issue of the Annals of Allergy, Asthma& Immunology by Zhang et al3 adds to a growing body of knowledge regarding this novel therapy.
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: Tags: Editorial Source Type: research